RingCentral to Present at Goldman Sachs and Piper Sandler Conferences
Get Alerts RNG Hot Sheet
Join SI Premium – FREE
BELMONT, Calif.--(BUSINESS WIRE)-- RingCentral, Inc. (NYSE: RNG), a global leader in AI-powered customer engagement, today announced that members of its management team are scheduled to present at the following investor conferences:
Goldman Sachs Communacopia + Technology Conference 2026
Date: Thursday, September 10, 2026
Time: 1:45 p.m. PT / 4:45 p.m. ET
Piper Sandler Growth Frontiers Conference
Date: Tuesday, September 15, 2026
Time: 2:30 p.m. PT / 4:30 p.m. CT
A live webcast and replay of these fireside presentations will be accessible on the Company’s investor relations website at ir.ringcentral.com.
About RingCentral
RingCentral is a global leader in AI–powered customer engagement, delivering an integrated platform for business phone, SMS, contact center, workforce engagement management, video collaboration, and messaging. Powered by advanced AI capabilities, RingCentral delivers intelligence at every phase of the conversation journey — before, during, and after each human interaction. With RingCentral, businesses can work smarter, respond faster, and connect more meaningfully with their customers. Visit ringcentral.com to learn more.
© 2026 RingCentral, Inc. All rights reserved. RingCentral and the RingCentral logo are trademarks of RingCentral, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260902359206/en/
Investor Relations Contact:
Steven Horwitz
[email protected]
Media Contact:
Mariana Leventis
[email protected]
Source: RingCentral, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ngarlawangga Aboriginal Corporation and Rio Tinto sign Interim Modernised Agreement
- Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Sets August Monthly Sales Record of 158 Units; Makes Further Steps in Reducing Debt and Optimizing FF’s Capital Structure;
- Cell Stem Cell: tBE-mediated Base Editing Therapy Achieves Durable Clinical Remission in Sickle Cell Disease and β-Thalassemia Across Different Genetic Backgrounds
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share